Form 4: Performant Director Sells Shares Post-Merger

A director of Performant Healthcare Inc. disposed of all common stock and restricted stock units following the company's merger into a subsidiary of Continental Buyer, Inc. for $7.75 per share.

Summary

• Director Shantanu Agrawal reported changes in beneficial ownership of Performant Healthcare Inc. securities.
• Disposed of 44,430 shares of Common Stock on October 21, 2025.
• Disposed of 35,616 Restricted Stock Units and an additional 25,251 Restricted Stock Units on October 21, 2025.
• All dispositions were a direct result of the Agreement and Plan of Merger dated July 31, 2025.
• Performant Healthcare Inc. merged with Prevail Merger Sub, Inc., a wholly-owned subsidiary of Continental Buyer, Inc., with Performant surviving as a wholly-owned subsidiary.
• Each share of Common Stock was canceled and converted into the right to receive $7.75 in cash.
• Restricted Stock Units, whether vested or unvested, were canceled for a lump sum cash payment equal to the number of underlying shares multiplied by the $7.75 merger consideration.
• Following these reported transactions, Shantanu Agrawal beneficially owns 0 shares of Common Stock and 0 derivative securities.

Sentiment

Score: 7

Explanation: The filing reports the completion of a merger, resulting in a cash payout for shareholders and RSU holders. This provides certainty and liquidity, which is generally positive for exiting investors, but marks the end of Performant as an independent public entity.

Positives

• Shareholders received a definitive cash payment of $7.75 per share, providing immediate liquidity and a clear return on investment.
• Holders of Restricted Stock Units also received a cash payout, converting their equity awards into immediate value.

Negatives

• Performant Healthcare Inc. ceased to be an independent publicly traded entity, removing its stock from public markets.
• The director no longer holds any beneficial ownership in the company, indicating a complete exit from equity interest.

Future Outlook

The filing indicates the completion of a merger where Performant Healthcare Inc. became a wholly-owned subsidiary of Continental Buyer, Inc., implying its future operations will be integrated under the new parent company.

Industry Context

This transaction reflects a consolidation trend within the healthcare services or technology sector, where larger entities acquire specialized companies to expand market share or capabilities. The cash-out merger provides a clear exit for Performant's public shareholders.

Comparison to Industry Standards

• Cash mergers are a standard mechanism for taking a public company private, offering immediate liquidity to shareholders.
• Without specific industry benchmarks for similar acquisitions at the $7.75 per share price, a direct comparison of the deal's value for shareholders is not possible based solely on this filing.

Stakeholder Impact

• Shareholders: Received $7.75 cash per share, providing immediate liquidity and a defined return on investment.
• Management: Director Agrawal's equity holdings were cashed out, aligning with the merger terms.
• Company (Performant): Ceases to be an independent public entity, becoming a wholly-owned subsidiary of Continental Buyer, Inc.

Next Steps

• Performant Healthcare Inc. will operate as a wholly-owned subsidiary of Continental Buyer, Inc.
• Public trading of Performant Healthcare Inc. common stock will cease.

Key Dates

Keywords

Performant Healthcare, PHLT, Merger, Acquisition, Continental Buyer, Form 4, Insider Transaction, Restricted Stock Units, Cash Payout, Director